Assessment of Hearing Impairment in Sick Newborns: A Prospective Observational Study

Jatin Nagal1, Ramesh Choudhary2, Mahendra Jain3

  • 1Department of Medical and Health, Government of Rajasthan, Jaipur, IND.

Cureus
|July 17, 2023
PubMed

Insights

Early hearing loss detection in high-risk newborns is crucial. A two-stage otoacoustic emissions test effectively identifies hearing impairment before automated auditory brainstem response screening.

Area of Science:

  • Neonatal care
  • Audiology
  • Pediatric neurology

Background:

  • Neonatal hearing loss can lead to severe developmental issues.
  • Sick newborns in the NICU have a significantly higher risk of hearing loss.
  • Early identification of hearing impairment in high-risk infants is critical.

Purpose of the Study:

  • To identify hearing impairment in high-risk neonates.
  • To assess the effectiveness of otoacoustic emissions and auditory brainstem response in detecting hearing loss.
  • To analyze risk factors associated with hearing impairment in neonates.

Main Methods:

  • Prospective observational study of 150 high-risk neonates admitted to the NICU.
  • Hearing assessment using distortion-product otoacoustic emissions (DPOAE) at discharge and six weeks.
  • Automated auditory brainstem response (AABR) testing at three months for infants with abnormal DPOAE results.

Main Results:

  • 55.33% of infants initially "referred" on DPOAE screening at discharge.
  • A two-stage DPOAE identified hearing impairment in 11 out of 33 infants tested with AABR.
  • Significant associations found between hearing impairment and neonatal hyperbilirubinemia, hypoxic ischemic encephalopathy, very low birth weight, and duration of mechanical ventilation.

Conclusions:

  • A two-stage DPOAE screening prior to AABR aids in early hearing loss detection.
  • Early identification allows for timely intervention to mitigate developmental consequences.
Abstract